-

Asahi Kasei participates in investment in Circularise B.V. of the Netherlands

NEW YORK & TOKYO--(BUSINESS WIRE)--Asahi Kasei, a diversified Japanese multinational company, has decided to invest in Circularise B.V., a startup company in the Netherlands that provides digital product passports and mass balance bookkeeping software, together with Brightlands Venture Partners, 4impact capital, and Neste, in November 2022.

Circularise is a startup company founded in 2016 aiming to accelerate the shift towards a circular economy through supply chain traceability and transparency. Circularise has developed a highly reliable supply chain management system that achieves both anonymity and transparency based on Smart Questioning1 technology utilizing Zero-Knowledge Proofs2 with a blockchain. By using these technologies, various information such as raw materials, recycling history, biomass and recycling content, carbon footprint, third-party certification, etc. can be traced through the supply chain while maintaining the confidentiality of each stakeholder's information.

The Asahi Kasei Group expects to contribute to a carbon neutral and sustainable world by joining the establishment of a digital platform ensuring reliability and transparency in the supply chain through its investment in Circularise, in accordance with its medium-term management plan focused on the theme “Be a Trailblazer.”

1 Smart Questioning: Circularise’s patent-pending method of using Zero-Knowledge Proofs (ZKP) to share essential and useful insights into product and material information throughout a supply chain over a public blockchain without sharing any specific data.

2 Zero-Knowledge Proofs (ZKP): a form of perfectly hiding encryption that allows sharing of useful insights into information without sharing any specific data. ZKPs can be used to share insight into the environmental impact of a product or material without sharing any specific data on the composition or manufacturing processes of a product.

About Circularise B.V.

Location

Wilhelmina van Pruisenweg 35, 2595 AN, Den Haag, Netherlands

Founders

Mesbah Sabur and Jordi de Vos

Establishment

July 2016

Operations

Providing a traceability platform in supply chains utilizing a blockchain, with digital product passports and mass balance bookkeeping software

Website

https://www.circularise.com/

About Asahi Kasei

The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 46,000 employees around the world, the company contributes to a sustainable society by providing solutions to the world's challenges through its three business sectors of Material, Homes, and Health Care. Its Material sector, comprised of Environmental Solutions, Mobility & Industrial, and Life Innovation, includes a wide array of products, from battery separators and biodegradable textiles to engineering plastics and sound solutions. For more information, visit https://www.asahi-kasei.com/.

Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon-neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/.

Contacts

Company Contact North America:
Asahi Kasei America, Inc.
Jon Todd
39475 W. Thirteen Mile Road, Suite 201, Novi, MI 48377
E-mail: AKA-info@ak-america.com

Company Contact Europe:
Asahi Kasei Europe GmbH
Sebastian Schmidt
Fringsstrasse 17, 40221 Düsseldorf
Tel: +49 (0) 211-3399-2058
E-mail: sebastian.schmidt@asahi-kasei.eu

Asahi Kasei

TOKYO:3407

Release Versions

Contacts

Company Contact North America:
Asahi Kasei America, Inc.
Jon Todd
39475 W. Thirteen Mile Road, Suite 201, Novi, MI 48377
E-mail: AKA-info@ak-america.com

Company Contact Europe:
Asahi Kasei Europe GmbH
Sebastian Schmidt
Fringsstrasse 17, 40221 Düsseldorf
Tel: +49 (0) 211-3399-2058
E-mail: sebastian.schmidt@asahi-kasei.eu

Social Media Profiles
More News From Asahi Kasei

Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics, Inc., the global specialty pharmaceutical business of Tokyo-based Asahi Kasei, with U.S. and European business headquarters in Cary, North Carolina, today announced that the U.S. Food and Drug Administration (FDA) has approved HOVILPRI® (pritelivir) 100 mg tablets for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) infection that is refractory (with or without documented resistance) to treatment with acyclovir, valacy...

Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall Elements

TOKYO--(BUSINESS WIRE)--Asahi Kasei Microdevices held a ceremony to celebrate the recognition of the 1983 commercialization of thin-film Hall elements as an IEEE Milestone....

Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics announced that the first patient has been dosed in a randomized Phase 2a clinical trial (NCT07503561) evaluating AIC468....
Back to Newsroom